Skip to content

Interest of a Specific Care Pathway for the Management of Catamenial Epilepsy

Interest of a Specific Care Pathway for the Management of Catamenial Epilepsy Catamenial Epilepsy: Status Report and Point of View of a Cohort of Patients Who for Drug-resistant Epilepsy at the TOULOUSE University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05898152
Acronym
EPICAT
Enrollment
50
Registered
2023-06-12
Start date
2023-05-03
Completion date
2024-11-03
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy Menstrual

Keywords

Catamenial epilepsy, Menstrual cycle

Brief summary

This is a study of patients with catamenial epilepsy. Catamenial epilepsies are defined as epileptic seizures during the menstrual cycle. Today, there are no recommendations and no care pathway for these patients. The aim of this study is to assess the number of patients reporting a link between the occurrence of their epileptic seizures and their menstrual cycle.

Interventions

OTHERData collection

A collection about patient's data demographic, neurologic and gynecologic follow-up and satisfaction will be review by questionnaire. And a calendar of epileptic seizures will be completed by patients on 4 months

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults patients (\>18 years) * No menopausal * Patients who have consulted in a Neurology department for refractory epilepsy * Non opposition patient * Affiliation to a social security scheme

Exclusion criteria

* Patients who understand French enough

Design outcomes

Primary

MeasureTime frameDescription
Number of reporting patients4 monthsNumber and proportion of patients reporting having a link between the onset of their epileptic seizures and their menstrual cycle based on the questionnaire they completed.

Secondary

MeasureTime frameDescription
Satisfaction of taking charge4 monthsQuestionnaire about satisfaction of management by the professional
Rate of women with drug-resistant epilepsy4 monthsCollection calendar
Listening satisfaction4 monthsQuestionnaire about listening satisfaction by the professional
Association between catamenial epilepsy and menstrual cycle4 monthsResearch of an association between catamenial epilepsy and menstrual cycle
Existing associations4 monthsEvaluate link between different factors obtained during the collection (contraceptions, epileptics, menstrual cycle disorders, etc.) and the presence of catamenial epilepsy
Reconciliation of catamenial epilepsy4 monthsComparison of epilepsy collection calendar and questionnaire. The questionnaire includes demographic data, neurological demographic data, their neurological and gynaecological follow-up, and also their satisfaction with their care and the information received on their pathology.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026